Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Goodwill (2016 - 2025)

Historic Goodwill for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to $1.5 billion.

  • Icu Medical's Goodwill rose 138.5% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 138.5%. This contributed to the annual value of $1.4 billion for FY2024, which is 269.44% down from last year.
  • As of Q3 2025, Icu Medical's Goodwill stood at $1.5 billion, which was up 138.5% from $1.5 billion recorded in Q2 2025.
  • Icu Medical's 5-year Goodwill high stood at $1.5 billion for Q1 2022, and its period low was $32.8 million during Q3 2021.
  • In the last 5 years, Icu Medical's Goodwill had a median value of $1.5 billion in 2024 and averaged $1.2 billion.
  • In the last 5 years, Icu Medical's Goodwill surged by 453360.65% in 2022 and then crashed by 420.08% in 2023.
  • Over the past 5 years, Icu Medical's Goodwill (Quarter) stood at $43.4 million in 2021, then skyrocketed by 3236.31% to $1.4 billion in 2022, then rose by 1.6% to $1.5 billion in 2023, then dropped by 2.69% to $1.4 billion in 2024, then rose by 4.61% to $1.5 billion in 2025.
  • Its Goodwill stands at $1.5 billion for Q3 2025, versus $1.5 billion for Q2 2025 and $1.5 billion for Q1 2025.